Bee pollen-derived peptide with dual DPP-IV Inhibition and glucose transport modulation

Key Points

• The peptide demonstrates dual inhibition of DPP-IV, a key enzyme in glucose metabolism, and modulation of glucose transport.
• This study reveals a significant decrease in glucose levels, with peptide application leading to a 30% reduction in glucose absorption.
• Analysis of bioactive compounds was conducted using in vitro assays to evaluate their effects on glucose metabolism and enzyme activity.
• These findings may enable new therapeutic strategies for managing metabolic disorders linked with glucose imbalance.